Trademark: 97423792
Word
LEUKEMIA & LYMPHOMA SOCIETY DARETODREAM PROJECT
Status
Pending
Status Code
760
Status Date
Tuesday, November 14, 2023
Serial Number
97423792
Mark Type
3000
Filing Date
Monday, May 23, 2022

Trademark Owner History

Classifications
41 Providing patient education services in the nature of classes, courses, and workshops in the field of cancer
36 Accepting and administering monetary charitable contributions in the field of cancer; medical research services in the field of cancer, namely, providing financial sponsoring for clinical trials
35 Promoting the interests of cancer patients and medical professionals in the field of cancer by means of public advocacy; promoting public awareness of cancer by means of public advocacy
45 Providing personal support services for patients and families of patients with cancer, namely, emotional counseling and emotional support in the field of cancer
44 Providing medical counseling and information about medical terms and clinical trials to patients, families, and healthcare providers in the field of cancer, including helping children, patients, caregivers, parents and physicians to identify appropriate clinical trials for children with cancer; providing information in the field of cancer treatment; providing nutritional consultations to patients, families, and caregivers in the field of cancer
42 Conducting clinical trials in the nature of medical research in the field of cancer; consulting services for others, namely, helping others design, plan, implement, and manage clinical trials in the field of cancer
The mark consists of a red drop design to the left of the wording "LEUKEMIA & LYMPHOMA SOCIETY" in grey, followed by a grey vertical line; to the right of the vertical line is the wording "DARETODREAM PROJECT" with "DARE" and "DREAM" in red and "TO" and "PROJECT" in grey, and a red star design in the upper right.
LEUKEMIA AND LYMPHOMA SOCIETY DARE TO DREAM PROJECT
"LEUKEMIA & LYMPHOMA SOCIETY" has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement; "LEUKEMIA & LYMPHOMA SOCIETY" has become distinctive of the goods/services as evidenced by the ownership on the Principal Register for the same mark for sufficiently similar goods/services of active U.S. Registration No(s). 5531343, 5531342, 5150184, 5098957, and 4132890
The color(s) red and grey is/are claimed as a feature of the mark.
"SOCIETY"

Trademark Events
Nov 15, 2023
Teas/Email Correspondence Entered
Nov 15, 2023
Correspondence Received In Law Office
Nov 14, 2023
Teas Request For Reconsideration Received
Nov 14, 2023
Ex Parte Appeal-Instituted
Nov 14, 2023
Jurisdiction Restored To Examining Attorney
Nov 14, 2023
Exparte Appeal Received At Ttab
Aug 14, 2023
Notification Of Final Refusal Emailed
Aug 14, 2023
Final Refusal E-Mailed
Aug 14, 2023
Final Refusal Written
Jul 10, 2023
Teas/Email Correspondence Entered
Jul 10, 2023
Correspondence Received In Law Office
Jul 10, 2023
Assigned To Lie
Mar 8, 2023
Teas Response To Office Action Received
Dec 9, 2022
Notification Of Non-Final Action E-Mailed
Dec 9, 2022
Non-Final Action E-Mailed
Dec 9, 2022
Non-Final Action Written
Dec 8, 2022
Assigned To Examiner
May 27, 2022
Notice Of Design Search Code E-Mailed
May 26, 2022
New Application Office Supplied Data Entered
May 26, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24